Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) announced today that it has closed its acquisition of Treximet® (sumatriptan / naproxen sodium) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE